alexa
Reach Us +1-217-403-9671
Pharmacogenomics Of Cancer Therapeutics: Molecular Structure, Drug Development, And Inter-patient Variability | 19786
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

5th World Congress on Bioavailability and Bioequivalence Pharmaceutical R&D Summit

Salah M Blaih
ScientificTracks Abstracts: J Bioequiv Availab
DOI: 10.4172/0975-0851.S1.017
Abstract
C ancer biomarkers are expressed as a result of the development and progression of the disease. These biomarkers are most relevant for identifying patients who are likely to benefit from a given treatment (right drug for the right patient). This approach should be utilized in cancer drug development as well as measuring patient?s response to therapy. Some examples of these targeted therapy and their associated design/discovery are discussed: Trastuzumab (Herceptin?) for treatment of breast cancer with HER2 overexpression; the tyrosine kinase inhibitors imatinib (Gleevec?) and nilotinib (Tasigna?), for treatment of BCR-ABL gene expression of Ph+ chronic myeloid leukaemia; vemurefenib (Zelboraf) in cases of melanoma with BRAF mutation; panitumumab (Vectibix?) and cetuximab (Erbitux?) therapy of K-Ras mutation-negative (wild-type), epidermal growth factor receptor (EGFR)-expressing, metastatic colorectal cancer. Pharmacogenetic data related to cancer therapy are also presented. Risks of developing severe, life-threatening toxicities of thiopurine (hematopoietic/ myelosuppression, TPMT*3A/*3C variants); the topoisomerase I inhibitor irinotecan (severe/fatal neutropenia, UGT1A1*28 allele); and the BCR-ABL tyrosine kinase inhibitor Nilotinib (hyperbilirubinemia, UGT1A1*28 allele) are shown
Biography
Salah M Blaih, PhD, RPh, FRSC is Professor of Chemistry and Biochemistry, Kent State University, USA. He received PhD in Pharmacy from The Ohio State University. He has teaching, research and authoring in pharmacy and chemistry for more than 25 years. He is World-wide invited speaker on quality of medicines/ compendia standards, pharmacogenomics, and medication safety. He is a Fellow of The Royal Society of Chemistry, two-time President of The American Chemical Society-Penn Ohio Section, board-certified pharmacist. He is a member of ACCP, AAPS, Rho Chi Pharmacy Honor Society. His biography has been included in Who?s Who in the World and Who?s Who in America
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version